11-16
Sat
17:20-18:00
201会议室CD（二层）
论文交流 2
17:20-17:25
Pattern of primary tumor residual and lymph node spread in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy with or without pembrolizumab
17:25-17:30
接受同步放化疗的食管鳞状细胞癌患者全身免疫炎症指数、肿瘤浸润淋巴细胞在临床预后中的价值
17:30-17:35
晚期食管癌系统性治疗联合/不联合局部放疗的疗效与安全性：一项荟萃分析
17:35-17:40
Dosimetric predictors of acute hematological toxicity During nCRT with or without pembrolizumab for esophageal squamous cell carcinoma
17:40-18:00
点评
